Message from the Director

Steven K. Libutti, MD, FACS

Welcome to Rutgers Cancer Institute of New Jersey. As one of the nation’s 47 NCI-designated Comprehensive Cancer Centers and the state’s only such center, patients can be confident that they are receiving the most advanced cancer care delivered by a compassionate team of internationally recognized experts close to home. Rutgers Cancer Institute provides its patients with access to the latest medicines and technology, as well as the most advanced clinical trials including novel personalized targeted therapies including precision medicine and immunotherapy. 

With state-of-the-art science thriving side by side with clinical research and patient care, our physicians and scientists are leaders in their field. They work diligently to develop new approaches to the detection, treatment and prevention of cancer through groundbreaking clinical, basic, population, and translational research all with one goal in mind – winning is everything!

As the cancer research hub for New Jersey, Rutgers Cancer Institute fosters collaborations with the State’s universities, as well as pharmaceutical and biotechnology companies bringing breakthrough discoveries to patients at a rapid pace. Rutgers Cancer Institute also serves as a valuable resource for New Jersey's pharmaceutical and biotechnology industries for the development of new cancer treatments.

I welcome you to explore our website and learn more about the incredible work being done at Rutgers Cancer Institute of New Jersey and how we are outsmarting cancer with science and caring for our patients with compassion.


Steven K. Libutti, MD, FACS
Director, Rutgers Cancer Institute of New Jersey
Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences
Senior Vice President of Oncology Services, RWJBarnabas Health


effective 3/6/17




precision medicine at Rutgers Cancer Institute




Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health